Abivax to Host KOL Investor Event to Review Phase 2B Clinical Data and Phase 3 Trial Design for Obefazimod in Patients with Moderately to Severely Active Ulcerative Colitis

Abivax SA announced the organization of a virtual KOL Investor Event on February 6, 2024. The event will feature Marla Dubinsky, MD, and Parambir Dulai, MD. Along with Abivax?s management, they will...

Related Keywords

Parambir Dulai ,Marla Dubinsky , ,Markets ,